Literature DB >> 27920237

von Willebrand Disease: A Concise Review and Update for the Practicing Physician.

Arjun Swami1, Varinder Kaur2,3.   

Abstract

von Willebrand disease (vWD) is the most common inherited disorder of hemostasis and comprises a spectrum of heterogeneous subtypes. Significant advances have been made in understanding von Willebrand factor ( vWF) gene mutations, resultant physiologic deficits in the vWF peptide, and their correlation to clinical presentation. Diagnostic tests for this disorder are complex, and interpretation requires a thorough understanding of the underlying pathophysiology by the practicing physician. The objective of this review is to summarize our current understanding of pathophysiology, laboratory investigations, and evolving treatment paradigm of vWD with the availability of recombinant von Willebrand factor.

Entities:  

Keywords:  VWD; diagnostic tests for vWD; laboratory testing of vWD; recombinant von Willebrand factor; von Willebrand disease; von Willebrand factor

Mesh:

Substances:

Year:  2016        PMID: 27920237     DOI: 10.1177/1076029616675969

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  8 in total

1.  Phenotypic and Genotypic Signatures of VWF Exon 18 in Eastern Saudi Patients Previously Diagnosed with Type 1 von Willebrand Disease.

Authors:  Faisal M Alzahrani; Asma A Al Faris; Layla A Bashawri; Fathelrahman Mahdi Hassan; Omar S El-Masry; Maryam A Aldossary; Osama Al Sultan; J Francis Borgio; Mohammed A Alsahli; Anne Goodeve
Journal:  Int J Gen Med       Date:  2022-06-02

Review 2.  VWF, Platelets and the Antiphospholipid Syndrome.

Authors:  Shengshi Huang; Marisa Ninivaggi; Walid Chayoua; Bas de Laat
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

3.  Gender-specific differences in haemostatic parameters and their influence on blood loss in bimaxillary surgery.

Authors:  Michael Schwaiger; Sarah-Jayne Edmondson; Jasmin Rabensteiner; Florian Prüller; Thomas Gary; Wolfgang Zemann; Jürgen Wallner
Journal:  Clin Oral Investig       Date:  2022-01-11       Impact factor: 3.573

4.  Clinicopathological Profile of the von Willebrand Disease in a Tertiary Care Centre in Varanasi.

Authors:  Pawan K Pandey; Vijai Tilak; Mahima Yadav; Neelu Kashyap
Journal:  J Lab Physicians       Date:  2021-09-08

Review 5.  Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities.

Authors:  Akshita Rana; Erik Westein; Be'eri Niego; Christoph E Hagemeyer
Journal:  Front Cardiovasc Med       Date:  2019-09-20

6.  Production of Extracellular Matrix Proteins in the Cytoplasm of E. coli: Making Giants in Tiny Factories.

Authors:  Anil A Sohail; Madhuri Gaikwad; Prakash Khadka; Mirva J Saaranen; Lloyd W Ruddock
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

7.  Two cases of von Willebrand disease type 3 in consanguineous Chinese families.

Authors:  Xiong Wang; Ning Tang; Yanjun Lu; Qun Hu; Dengju Li
Journal:  Mol Genet Genomic Med       Date:  2019-12-02       Impact factor: 2.183

Review 8.  Lipids and Antiplatelet Therapy: Important Considerations and Future Perspectives.

Authors:  Nina Đukanović; Slobodan Obradović; Marija Zdravković; Siniša Đurašević; Maja Stojković; Tomislav Tosti; Nebojša Jasnić; Jelena Đorđević; Zoran Todorović
Journal:  Int J Mol Sci       Date:  2021-03-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.